Inactive Instrument

Kindred Biosciences, Inc.

KIN

US4945771099

Biotechnology & Medical Research

Kindred Biosciences, Inc. Announces Retirement of Wendy Wee as Secretary, Effective August 31, 2021

February 01, 2021 at 04:18 pm EST

On January 28, 2021, Wendy Wee notified Kindred Biosciences, Inc. that she intends to retire as Secretary of company on August 31, 2021.

Latest news about Kindred Biosciences, Inc.

ObsEva Names Chief Strategy Officer	22-02-01	MT
Vaxart, Inc. acquired KindredBio's manufacturing equipment and GMP manufacturing facility in California from Kindred Biosciences, Inc.	21-11-30	CI
Kindred Biosciences, Inc. Announces Board Changes	21-08-30	CI
Elanco Animal Health Incorporated : Closes Purchase of Kindred Biosciences for About $444 Million	21-08-30	MT
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from S&P Global BMI Index	21-08-30	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from S&P TMI Index	21-08-30	CI
Kindred Biosciences, Inc.(NasdaqGM:KIN) dropped from NASDAQ Composite Index	21-08-27	CI
Elanco Animal Health Incorporated completed the acquisition of Kindred Biosciences, Inc..	21-08-26	CI
Today on Wall Street: Markets ride momentum ahead of Jackson Hole	21-08-23
ANALYST RECOMMENDATIONS : Adobe, Baozun, Fafetch, Hydro One, Ontrak	21-08-23
KINDRED BIOSCIENCES : Stifel Nicolaus Downgrades Kindred Biosciences to Hold From Buy, Keeps $9 Price Target	21-08-20	MT
Kindred Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-05	CI
Insider Trends: Kindred Biosciences Insider Continues 90-Day Selling Trend	21-07-07	MT
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 3000E Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 2500 Growth Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 2000 Value Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 2500 Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 2000 Growth Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell Small Cap Comp Value Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell Small Cap Completeness Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 2500 Value Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell Small Cap Comp Growth Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 3000 Growth Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 3000 Value Index	21-06-25	CI
Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from Russell 3000E Value Index	21-06-25	CI

Chart Kindred Biosciences, Inc.

Duration

Period

More charts

Kindred Biosciences, Inc. is a United States-based company. The Company is a veterinary biopharmaceutical company developing medicines for cats, dogs and horses. Its product is Zimeta (dipyrone injection). The Company is engaged in revolutionizing veterinary therapeutic biologics, such as monoclonal antibodies and recombinant proteins.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+9.42%	115B
REGENERON PHARMACEUTICALS, INC.	+11.84%	106B
ARGENX SE	-2.30%	21.96B
BIONTECH SE	-14.15%	21.87B
GENMAB A/S	-5.29%	19.21B
BEIGENE, LTD.	-4.16%	18.08B
WUXI APPTEC CO., LTD.	-38.29%	17.71B
NEUROCRINE BIOSCIENCES, INC.	+7.99%	14.32B
SAREPTA THERAPEUTICS, INC.	+36.24%	12.42B

Bio Therapeutic Drugs